Alkermes ALKS
NASDAQ ALKS
$46.17 +0.27 (+0.59%)
At close: Nov 9, 2026 · 4:00 PM EST

Alkermes (ALKS) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Alkermes (ALKS) reported Depreciation & Amortization (CF) of $27.16 million for Q3 2026, up 236.1% from $8.08 million a year earlier but down 10.3% from the prior quarter.

Analysis

Alkermes (ALKS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Alkermes' Depreciation & Amortization (CF) came in at $80.71 million, up 167.6% year-over-year; for FY2025, it came in at $27.17 million, down 4.8% from FY2024.

  • Depreciation & Amortization (CF) has declined for five consecutive years, with a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $28.53 million in FY2024 (-61.9%), $74.93 million in FY2023 (-3.8%), $77.86 million in FY2022 (-1.0%) and $78.65 million in FY2021 (-3.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $3.85 million in Q4 2025 and a high of $30.28 million in Q2 2026.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last three quarters, with growth averaging 75.5% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2026 (growth of 287.3%); the low point was Q2 2024 (a decline of 65.0%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $30.28 million (Q2 2026), $19.43 million (Q1 2026) and $3.85 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.12 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 192.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 132.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.58 Bn
10 Alkermes 7.77 Bn 5.26 Bn 385.91 Mn 27.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.16 Mn
Jun 30, 2026 30.28 Mn
Mar 31, 2026 19.43 Mn
Dec 31, 2025 3.85 Mn
Sep 30, 2025 8.08 Mn
Jun 30, 2025 7.82 Mn
Mar 31, 2025 7.42 Mn
Dec 31, 2024 6.85 Mn
Sep 30, 2024 6.97 Mn
Jun 30, 2024 6.66 Mn
Mar 31, 2024 8.06 Mn
Dec 31, 2023 18.54 Mn
Sep 30, 2023 18.66 Mn
Jun 30, 2023 19.01 Mn
Mar 31, 2023 18.71 Mn
Dec 31, 2022 19.68 Mn
Sep 30, 2022 19.60 Mn
Jun 30, 2022 19.39 Mn
Mar 31, 2022 19.20 Mn
Dec 31, 2021 21.14 Mn
API Access

Alkermes Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALKS&period=max&api_key=YOUR_API_KEY